Cardio Diagnostics (CDIO) to Release Earnings on Monday

Cardio Diagnostics (NASDAQ:CDIO) is expected to announce its earnings results before the market opens on Monday, April 7th. Analysts expect the company to announce earnings of ($0.16) per share and revenue of $0.03 million for the quarter.

Cardio Diagnostics Price Performance

NASDAQ:CDIO opened at $0.31 on Friday. The firm has a 50-day moving average of $0.46 and a two-hundred day moving average of $0.48. Cardio Diagnostics has a 1-year low of $0.19 and a 1-year high of $1.77.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.